Jon P. Stonehouse - May 13, 2024 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
May 13, 2024
Transactions value $
$166,500
Form type
4
Date filed
5/15/2024, 07:08 AM
Previous filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Purchase $167K +30K +2.73% $5.55 1.13M May 13, 2024 Direct F1
holding BCRX Common Stock 20K May 13, 2024 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding BCRX Common Stock 20K May 13, 2024 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.34 to $5.68. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.